EMA (EU)
GUIDANCE FINAL
Draft guideline on the investigation of interactions in the gastrointestinal tract
Published: 9/11/2026Detected: 9/11/2026
Summary preview
Provides updated EMA recommendations for investigating and interpreting gastrointestinal absorption-related drug interactions driven by extrinsic factors such as food, gastric pH/acid-reducing agents…
Get the full analysis, free
Create a free account to see the complete summary, key takeaways, and why this matters for your products, and to get alerts like this by email.
Create free accountgastroenterology
clinical
safety
quality
clinical
labeling
manufacturing
#gastrointestinal tract
#drug-drug interaction
#food effect
#gastric pH
Official Source Document Source Verified
Access the original document directly from EMA.
More from EMA (EU)
- Pharmacovigilance Risk Assessment Committee (PRAC): 23 - 26 November 202611/23/2026
- Seventeenth meeting of the industry stakeholder platform on the operation of the centralised procedure for human medicines11/20/2026
- EMA annual call with General Practitioner Organisations' representatives11/20/2026
- Digitalisation and artificial intelligence in pharmaceutical manufacturing: Quality Innovation Group (QIG) - Follow-up roundtable meeting11/18/2026
- Meeting of the Executive Steering Group on Shortages and Safety of Medicinal Products (MSSG) - November 202611/18/2026